Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Q1 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Jul 31, 2024 / 10:30AM GMT
Release Date Price: €25.21 (-0.20%)

Jul 31, 2024 / 10:30AM GMT
Presentation
Jul 31, 2024 / 10:30AM GMT

=====================
Corporate Participants
=====================
* Christopher David O'Reilly
Takeda Pharmaceutical Co Ltd - Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Julie Kim
Takeda Pharmaceutical Co Ltd - President of US Business Unit

=====================
Conference Call Participants
=====================
* Hiroyuki Matsubara
Nomura Securities Co., Ltd. - Analyst
* Steve Barker
Jefferies Group (Trades,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot